Neurizon Therapeutics Limited current ratio

The Current Ratio as of October 2026 (TTM) for Neurizon Therapeutics Limited (NUZ.AX) is 2.16

According to Neurizon Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.16. This represents a change of -24.60% compared to the average of 2.87 of the last 4 quarters.

Neurizon Therapeutics Limited (NUZ.AX) Historical Current Ratio (quarterly & annually)

How has NUZ.AX Current Ratio performed in the past?

The mean historical Current Ratio of Neurizon Therapeutics Limited over the last ten years is 3.93. The current 2.16 Current Ratio has changed -44.91% with respect to the historical average. Over the past ten years (40 quarters), NUZ.AX's Current Ratio was at its highest in in the June 2024 quarter at 12.42. The Current Ratio was at its lowest in in the December 2006 quarter at 0.

Neurizon Therapeutics Limited (NUZ.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Neurizon Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurizon Therapeutics Limited (NUZ.AX) Average Current Ratio

How has NUZ.AX Current Ratio performed in the past?

The current Current Ratio of Neurizon Therapeutics Limited (NUZ.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neurizon Therapeutics Limited (NUZ.AX) Current Ratio vs. Peers

How is NUZ.AX’s Current Ratio compared to its peers?

Neurizon Therapeutics Limited’s Current Ratio is less than Live Verdure Ltd (3.16), less than Kazia Therapeutics Limited (2.87), less than Bionomics Limited (27.85), greater than Medlab Clinical Limited (0.12), less than Hexima Limited (38.26), greater than Regeneus Ltd (0.28), less than Antisense Therapeutics Limited (7.64), less than Exopharm Limited (2.67), greater than Respiri Limited (1.18), less than Living Cell Technologies Limited (17.89),

Build a custom stock screener for Neurizon Therapeutics Limited (NUZ.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurizon Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurizon Therapeutics Limited (NUZ.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurizon Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.